VX15/2503 is a humanized IgG4 monoclonal antibody that can specifically bind to SEMA4D and prevent SEMA4D binding to its receptor [18], which is critical in the physiological process of tumor growth and immune cell regulation [19]. The gene discussed is SEMA4D; the disease is neoplasm.